Prestige Consumer Healthcare PBH Ratios (2010-2026)

NYSE PBH
$48.70 -1.09 (-2.19%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Prestige Consumer Healthcare Quarterly Ratios

Periods 64 quarters
Latest Mar 2026

Prestige Consumer Healthcare ratios data for the quarter ended Mar 2026. These financial ratios cover 64 quarters of results from Jun 2010 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
Gross Margin
59.07%57.10%56.49%55.77%57.79%55.66%54.59%53.79%55.38%55.89%55.86%54.81%54.66%55.46%55.47%57.34%56.24%55.30%55.52%
EBT Margin
28.37%21.59%23.86%22.84%25.59%23.02%24.72%-104.78%24.60%24.59%24.61%24.30%21.87%25.25%27.61%24.94%24.76%25.22%21.81%
EBIT Margin
33.93%28.44%30.09%29.01%31.41%29.17%31.64%-98.30%30.50%30.82%30.71%29.66%26.97%29.72%31.68%29.82%28.76%29.06%29.10%
EBITDA Margin
33.93%28.44%30.09%29.01%31.41%29.17%31.64%-98.30%30.50%30.82%30.71%29.66%26.97%29.72%31.68%29.82%28.76%29.06%29.10%
Operating Margin
33.93%28.44%30.09%29.01%31.41%29.17%31.64%-98.30%30.50%30.82%30.71%29.66%26.97%29.72%31.68%29.82%28.76%29.06%29.10%
Net Margin
21.46%16.41%18.30%19.51%19.95%17.64%18.86%-84.15%19.07%18.71%18.76%17.86%18.37%19.16%21.02%16.91%19.02%15.40%16.47%
FCF Margin
25.19%21.16%23.34%22.46%20.65%19.07%19.29%19.74%16.69%20.79%24.57%23.02%20.07%23.88%21.88%19.68%31.33%20.20%26.55%
Efficiency
Inventory AverageInventory Avg.
110.25M106.73M107.10M113.31M127.06M137.14M149.51M160.32M165.99M165.57M154.96M143.68M145.38M154.13M153.87M149.61M150.42M156.06M161.29M161.36M
Assets AverageAssets Avg.
3,494.19M3,617.47M3,667.61M3,665.04M3,676.46M3,680.37M3,714.14M3,551.75M3,349.65M3,339.23M3,336.31M3,329.09M3,312.97M3,312.20M3,323.19M3,365.86M3,416.92M3,436.95M3,468.51M3,494.53M
Invested CapitalInvested Cap.
2,961.60M3,060.63M3,048.62M3,054.27M3,057.17M3,058.18M3,110.96M2,792.87M2,797.01M2,798.93M2,799.92M2,780.89M2,771.97M2,783.35M2,780.40M2,827.25M2,848.23M2,818.11M2,863.00M2,881.47M
Asset Utilization RatioAsset Util.
0.280.280.290.300.300.300.300.320.340.340.340.340.340.340.340.340.330.320.32
Leverage & Solvency
Interest Coverage RatioInterest Cover
4.815.015.245.486.878.03
Debt Ratio
0.430.440.420.400.400.390.380.400.390.380.360.340.330.320.300.290.290.290.300.28
Times Interest Earned
4.815.015.245.486.878.03
Valuation
Price to EarningsP/E
45.1662.0360.6351.1052.9448.3759.87-12.9455.2652.9857.3073.2369.5465.5163.3884.7582.7971.0862.51
Price to SalesP/S
9.6910.1811.099.9710.568.5311.2910.8910.549.9110.7513.0812.7712.5513.3214.3315.7510.9510.30
Price to BookP/B
1.841.922.011.691.851.521.842.151.991.851.902.192.032.062.162.322.121.641.601.77
Enterprise Value
2,444.50M2,768.53M3,023.57M2,634.61M2,890.17M2,425.44M3,024.09M3,053.76M2,889.55M2,777.62M2,975.91M3,575.39M3,377.77M3,510.59M3,817.54M4,150.30M3,790.25M2,881.34M2,856.72M3,267.76M
EV to EBIT
26.7635.2436.6134.0333.2228.7434.69-10.8733.9231.4734.2743.5246.8841.6241.5146.9352.8236.1734.63
EV to EBITDA
26.7635.2436.6134.0333.2228.7434.69-10.8733.9231.4734.2743.5246.8841.6241.5146.9352.8236.1734.63
Market Capitalization
2,608.13M2,811.34M3,044.58M2,661.79M2,926.04M2,467.88M3,110.45M3,112.25M2,944.13M2,837.69M3,039.53M3,621.86M3,412.02M3,562.13M3,868.41M4,248.18M3,929.75M3,000.44M2,919.09M3,331.63M
Price to FCFP/FCF
38.4748.1047.5244.3951.1544.7458.5355.1563.1747.6743.7556.8063.6352.5660.9072.7850.2754.1838.79
EV to FCF
36.0547.3747.1943.9450.5343.9756.9154.1261.9946.6642.8356.0762.9951.8060.1071.1048.4852.0237.96
EV to CFO
35.2745.2445.6141.7449.6242.1555.0451.7760.0944.4741.6453.4461.6750.3058.6567.1047.9750.1236.49
Return Ratios
Return on Sales [ROS]ROS
33.93%28.44%30.09%29.01%31.41%29.17%31.64%-98.30%30.50%30.82%30.71%29.66%26.97%29.72%31.68%29.82%28.76%29.06%29.10%
Return on Capital Employed [ROCE]ROCE
9.16%9.06%9.16%9.37%9.25%9.39%9.45%-0.66%-0.76%-0.63%-0.65%10.66%10.29%10.15%10.26%10.33%10.17%10.05%9.68%
Return on Invested Capital [ROIC]ROIC
8.56%8.14%8.27%8.46%8.41%8.57%8.59%-0.67%-0.76%-0.65%-0.66%9.31%9.16%9.04%9.16%9.07%8.78%8.25%7.94%
Return on Assets [ROA]ROA
5.12%4.96%5.15%5.60%5.52%5.67%5.66%-2.32%-2.52%-2.45%-2.42%6.29%6.19%6.22%6.44%6.38%6.23%5.84%5.38%